Stephen M. Bloch, Chairman of Liquidia Corporation (LQDA), recently sold 70,234 shares in open-market transactions valued at approximately $2.53 million, according to a SEC Form 4 filing. This sale, representing 3.02% of his total reported holdings, was executed through an indirect entity, Canaan VIII, L.P., leaving Bloch with a direct stake of 65,712 shares.
This transaction is noteworthy for investors as it aligns with portfolio rebalancing rather than signaling a loss of confidence in Liquidia. The sale occurred while the stock was on an upswing, reaching a 52-week high of $46.67 in February, driven by strong business performance. Liquidia reported significant revenue growth, with sales soaring to $158.3 million in 2025 from just $14 million in 2024, and achieving net income in the fourth quarter after a prior year loss.
Investors may find Liquidia’s current valuation appealing, especially given its recent profitability and the success of its YUTREPIA product, suggesting potential for continued growth in the biopharmaceutical sector.
Source: fool.com